Corline Biomedical AB (STO:CLBIO)
Sweden · Delayed Price · Currency is SEK 17.85
+0.40 (2.29%)
Jan 21, 2026, 11:47 AM CET
Corline Biomedical AB Market Cap
Corline Biomedical AB has a market cap or net worth of 446.96 million as of January 21, 2026. Its market cap has increased by 136.87% in one year.
Market Cap
446.96M
Enterprise Value
441.14M
Revenue
8.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.85
Market Cap Chart
Since June 3, 2015, Corline Biomedical AB's market cap has increased from 97.97M to 446.96M, an increase of 356.24%. That is a compound annual growth rate of 15.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 446.96M | 26.81% |
| Dec 30, 2025 | 352.45M | 86.79% |
| Dec 30, 2024 | 188.69M | -41.07% |
| Dec 29, 2023 | 320.21M | 61.61% |
| Dec 30, 2022 | 198.15M | -36.85% |
| Dec 30, 2021 | 313.77M | 25.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 41.24B |
| Medicover AB | 31.93B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |